Handelsavisen
prelaunch
Companies 1318.HK
13
1318.HK HKEX Unclassified

Mao Geping Cosmetics Co Ltd

HK$59,55
Open in Charts → Attach watcher ⌖
HKD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
29,2B HKD
P/E
EV / Rev
Div yield
2,07 %
Op margin
31,6 %
ROE
25,8 %
Net margin
23,8 %
Debt / equity
0,02
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Mao Geping Cosmetics Co Ltd operates in the personal care products sector, generating revenue through the sale of cosmetics and related consumer staples.

Business. Mao Geping Cosmetics Co Ltd operates in the personal care products sector, generating revenue through the sale of cosmetics and related consumer staples.

Classification20 %
SectorUnclassified
Generated · model-assisted
Sell-side consensus
BUY19 analysts
18 buy1 hold0 sell
Avg 12m price target101,96

Analyst recommendations

19 analysts · consensus Buy
Buy18
Hold1
Sell0
12-month price target
101,96
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
19 analysts · indicative
Ownership
not yet wired
Profitability
25,8 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 1318.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 1318.HK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Mao Geping Cosmetics Co Ltd operates in the personal care products sector, generating revenue through the sale of cosmetics and related consumer staples.

    Classification20 %
    SectorUnclassified
    AI synthesis
    GENERATED

    Mao Geping Cosmetics maintains a robust capital structure characterized by minimal leverage and strong liquidity. The company holds CNY 2.44 billion in cash and equivalents against total liabilities of CNY 867 million, resulting in a debt-to-equity ratio of 0.02 and a current ratio of 5.2. This balance sheet strength supports a low liquidity risk assessment, with no immediate filing-based flags detected. The firm generates substantial free cash flow of CNY 756 million, indicating efficient capital management and the ability to self-fund operations without significant external financing.

    Profitability metrics demonstrate high operational efficiency, with a return on equity of 25.8% and a return on assets of 21.8%. The gross profit of CNY 4.25 billion represents a significant margin on CNY 5.05 billion in revenue, while operating income stands at CNY 1.60 billion. These returns suggest a strong economic moat within its niche, although specific cohort median comparisons are unavailable to benchmark relative performance. The net income of CNY 1.20 billion underscores the company's ability to convert top-line growth into bottom-line earnings effectively.

    Revenue concentration and geographic exposure details are not explicitly provided in the available segment or geography data. Without specific breakdowns, the analysis relies on the aggregate revenue figure of CNY 5.05 billion as the primary indicator of scale. The absence of detailed segment data limits the ability to assess diversification risks or regional dependencies, necessitating a focus on the consolidated financial performance.

    Growth trajectory analysis is constrained by the absence of historical period data in the input. Consequently, year-over-year revenue or net income trends cannot be calculated from the provided structured data. The current valuation multiples, including a P/E of 21.27 and EV/EBITDA of 14.55, reflect market expectations for future growth rather than historical performance. The lack of historical context prevents a definitive assessment of the sustainability of current earnings levels.

    Risk factors are assessed as low for both liquidity and dilution. The company has no immediate filing-based liquidity or dilution flags, and the basic and diluted shares outstanding are identical at 490.2 million, indicating no current dilutive securities in the money. The primary risks appear to be operational or market-related rather than financial, given the strong balance sheet and cash position.

    Recent events and market sentiment indicate strong analyst confidence, with a mean price target of CNY 101.96 and a median target of CNY 105.00, significantly above the current market price of CNY 52.25. The mean recommendation of 1.58, driven by 9 strong buy and 9 buy ratings, suggests widespread institutional optimism. No specific filing, news, or transcript observations were provided to detail recent corporate actions or strategic announcements.

    Key takeaways
    • Strong balance sheet with CNY 2.44 billion in cash and negligible debt (D/E 0.02).
    • High profitability with ROE of 25.8% and ROA of 21.8%.
    • Significant analyst upside implied by mean price target of CNY 101.96 vs current price of CNY 52.25.
    • Low dilution risk with identical basic and diluted share counts.
    • Lack of historical data limits growth trend analysis.
    • No segment or geographic data available for concentration risk assessment.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    HK$59,55
    Market cap
    HK$25.61B
    Enterprise value
    HK$23.25B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    19.4x
    P / B
    5.5x
    P / Tangible book
    5.5x
    Tangible book
    HK$4.67B
    Net cash
    HK$2.36B
    Current ratio
    5.2
    Debt / equity
    0.0
    ROA
    21.8%
    ROE
    25.8%
    Cash conversion
    100.0%
    CapEx / revenue
    -3.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Beauty Products
    low · llm_fanout_v2
    Personal Care Products
    low · llm_fanout_v2

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    3,15
    Predicted surprise
    -0,08
    Beat probability
    45 %
    Analysts
    19
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    revision ratio -0,01 · as of 2026-07-09 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate3,15
    Revenueno estimateno estimate6,5B CNY
    Operating incomeno estimateno estimate2,0B CNY
    Full-year consensus mean (period as reported by source) · consensus in CNY. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution19 analysts
    Strong buy9
    Buy9
    Hold1
    Sell0
    Strong sell0
    12-month price targetHK$101,96 · Median HK$105,00
    Low HK$70,00High HK$129,40
    Operating income · consensus2,0B CNY
    EPS surprise
    −21,8 %
    reported vs consensus · miss
    Revenue surprise
    −22,4 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    LowHK$70,00
    MeanHK$101,96
    MedianHK$105,00
    HighHK$129,40
    SpotHK$59,55
    +71.2 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin31,6 %Best in class
    Net Margin23,8 %Best in class
    ROE25,8 %Best in class
    Capex / Rev-3,7 %Above median
    D/E0,02Above P75
    Cash Conv1,00Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Market Cap
      market_price * shares_outstanding_diluted
    • Ev To Revenue
      enterprise_value / revenue
    • Return On Assets
      net_income / total_assets
    • Price To Tangible Book
      market_price / (tangible_book_value / shares_outstanding_diluted)
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    Source documents
    • Mao Geping Cosmetics Co Ltd Market data — financials · 2026-07-09
    • Mao Geping Cosmetics Co Ltd Market data — analyst estimates · 2026-07-09

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    1318.HKCanonical
    HKEX · HKD

    Intel & risk

    PredictorBeat prob45 %Surprise-0,08Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage